TCIM
KNSA icon

TIAA CREF Investment Management’s Kiniksa Pharmaceuticals KNSA Stock Holding History

TIAA CREF Investment Management’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$182K Buy
10,102
+1,924
+24% +$37.2K ﹤0.01% 2897
2018
Q4 		$230K Sell
8,178
-5,060
-38% -$106K ﹤0.01% 2847
2018
Q3 		$338K Buy
+13,238
New +$257K ﹤0.01% 2853

Other funds holding KNSA

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return

TIAA CREF Investment Management's KNSA Position: Q1 2019 in Review

TIAA CREF Investment Management increased its Kiniksa Pharmaceuticals (KNSA) stake by 24% in Q1 2019, buying an estimated $37.2K and bringing the position to 10,102 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #2897.

TIAA CREF Investment Management first reported a position in KNSA in Q3 2018 and has held it in 3 quarters since. The position peaked at $338K in Q3 2018. 56 funds tracked by Wall St. Rank hold KNSA as of Q1 2019.

  • TIAA CREF Investment Management held 10,102 shares of Kiniksa Pharmaceuticals worth $182K as of Q1 2019.
  • TIAA CREF Investment Management bought 1,924 Kiniksa Pharmaceuticals shares in Q1 2019, an estimated $37.2K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2897 holding.
  • TIAA CREF Investment Management first reported a position in Kiniksa Pharmaceuticals in Q3 2018 and has held it in 3 quarters since.
  • TIAA CREF Investment Management's Kiniksa Pharmaceuticals position peaked at $338K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.